Serum metalloproteinase leukolysin (MMP-25/MT-6): A potential metabolic marker for atopy-associated inflammation

Clinical and Experimental Allergy

Volumn 40, Issue 6, 2010, Pages 859-866

  Blumenthal, M N ^a   Zhong, W ^b   Miller, M ^a   Wendt, C ^c   Connett, J E ^b   Pei, D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Division of Biostatistics   (United States)

^c Division of Critical Care   (United States)

Author keywords

Asthma; Atopy; COPD; IgE; Leukolysin; Matrix metalloproteinase

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 1; LEUKOLYSIN; METALLOPROTEINASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 25;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; BONE MARROW CELL; BRONCHUS HYPERREACTIVITY; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; FAMILY HISTORY; FEMALE; HERITABILITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; ASTHMA; BLOOD; CAUCASIAN; FAMILY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GPI-LINKED PROTEINS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; YOUNG ADULT;

EID: 77952045075     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03475.x     Document Type: Article

References (20)

1. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function and biochemistry. Circ Res 2003 92 : 827 839. (Pubitemid 36542523)
2. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Develop 2000 14 : 2123 2133.
3. Lee M-H, Murphy G. Matrix metalloproteinases at a glance. J Cell Sci 2004 117 : 4015 4016. (Pubitemid 39328289)
4. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001 2 : 10 9.
5. Elkington PTG, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006 61 : 259 266.
6. Gueders MM, Foidart J-M, Noel A, Cataldo DD. Martrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: practical implications in asthma and other lung diseases. Eur J Pharmacol 2006 533 : 133 144. (Pubitemid 43340010)
7. Pei D. Leukolysin/MMP25/MT6-MMP; a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res 1999 9 : 291 303. (Pubitemid 129623934)
8. Kang T, Yi J, Guo A et al. Subcellular distribution and cytokine and chemokine-regulated secretion of Leukolysin/MT6 MMP/MMP-25 in neutrophils. J Biol Chem 2001 276 : 21960 21968. (Pubitemid 37413203)
9. English WR, Velasco G, Stracke JO, Knäuper V, Murphy G. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett 2001 491 : 137 142. (Pubitemid 32172018)
10. Kojima S, Itoh Y, Matsumoto S, Masuho Y, Seiki M. Membrane-type 6 metalloproteinase (MT-6, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett 2000 480 : 142 146.
11. Busse WW, Lemanske RF Jr. Asthma. New Engl J Med 2001 344 : 350 362. (Pubitemid 32107645)
12. Collaborative Study on the Genetics of Asthma (CSGA). A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997 15 : 389 392.
13. Anthonisen NR, Connett JE, Kiley JP et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1984 272 : 1497 1505.
14. Palmer LJ, Burton PR, Faux JA, James AL, Musk AW, Cookson WOCM. Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med 2000 161 : 1836 1843.
15. Nie J, Pei D. Direct activation of pro-matrix metalloproteinase-2 by leukolysin membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the Asn109-Tyr bond. Cancer Res 2001 63 : 6758 6762. (Pubitemid 37322956)
16. Nie J, Pei D. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp Cell Res 2004 296 : 145 150. (Pubitemid 38624636)
17. Geha RF, Jabara HH, Brodeur SR. The regulation of immunoglo-bulin E class-switch recombination. Nat Rev Immunol 2003 3 : 721 732.
18. Mayer RJ, Flamberg PL, Katchur SR et al. CD23 shedding; requirements for substrate recognition and inhibition by dipeptide hydroxamic acids. Inflamm Res 2002 51 : 85 90.
19. Christie G, Barton A, Bolognese B et al. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII). Eur J Immunol 1997 27 : 3228 3235. (Pubitemid 28018019)
20. Marolewski AE, Buckle DR, Christie G et al. CD23 (FcεRII) release from cell membranes is mediated by a membrane-bound metalloproteinase. Biochem J 1998 333 : 573 579. (Pubitemid 28398523)